FrontPage is India's Stock Market Social Network
Join 50,000+ Traders and Investors
forum

LUPIN Share Price Discussion

Lupin Ltd.
Sector: Pharmaceuticals and health care
... Read more
LUPIN Long Term Analysts Rating
3.2/5 (18 Ratings)
LUPIN Share Price *
739.65 +1.8 (0.24%)
* (quote may be delayed)

Find answers to all your questions on live LUPIN message board: Is LUPIN buy or sell? Should I buy LUPIN shares? Why are LUPIN shares falling? Should I invest in LUPIN stock?


You can also check LUPIN share price target recommended by brokerages.

LUPIN Discussion Forum

@commodityBiz • Reputation: 2,552

LUPIN - 555899
👆👆👆👆👆Suggestion :- SELL IF PRICE COMES AGAIN AT 745 WITH SL OF 747 FOR TARGET OF 735
EXPECTATION OF TARGET- 1 DAYS
SIGNAL TYPE - STRONG TIME FRAME- 1 HOURS
Like
reply
Reply
@kailashpatil • Reputation: 1,877
LUPIN JAN20 740 PE

Type
Buy
Instrument
LUPIN JAN20 740 PE
Entry Price
₹10.5
Price@Trade
₹10.5
Target Price
₹25
Stop Price
₹2
Valid Till
Jan 30, 2020 3:20 PM
Margin
₹7,350 approx for 700 Qty
Status
Active
Like
reply
Reply
@rkk-S1XHdc69E • Reputation: 80
RKK in LUPIN
But Lupin future @ 735-740 SL below 725 target ...

Even market fall but Lupin was intact, closed c2c or small profits
Like
reply
Reply
@tradingfab • Reputation: 752

22-01-20
LUPIN JAN PE 730 (Intraday)
only Above @ 9.30
Like
reply
Reply (1)
Latest replies
Sameer  @tradingfab
Jan 22 6:08 PM

cancel the order as buy price above @9.30 not yet triggered
@mpriceplotting • Reputation: 1,035

TTTE bullish for Lupin is 733
and Many more trade setup which you can do on your own with levels and just 1 hr in evening.
Like
reply
Reply
@rkk-S1XHdc69E • Reputation: 80

But Lupin future @ 735-740 SL below 725 target 750-754-758-762
Like
reply
Reply
@RajGala • Reputation: -588
LUPIN FEB20 FUT

Type
Buy
Instrument
LUPIN FEB20 FUT
Entry Price
₹746.5
Price@Trade
₹746.5
Target Price
₹780
Stop Price
₹725
Valid Till
Feb 27, 2020 3:20 PM
Margin
₹92,076.29 approx for 700 Qty
Status
Active
Like
reply
Reply
@TTA • Reputation: 8,717
LUPIN JAN20 FUT

Type
Buy
Instrument
LUPIN JAN20 FUT
Entry Price
₹742.9
Price@Trade
₹742.9
Target Price
₹759.9
Stop Price
₹727.9
Valid Till
Jan 28, 2020 3:20 PM
Margin
₹91,653.12 approx for 700 Qty
Status
Active
Like
reply
Reply (2)
Latest replies
Prudhvii @prudhvii
Jan 21 5:28 PM

Intraday?
TTA @TTA
Jan 21 5:31 PM
@intradaytadka • Reputation: 572

FUTURE LOVER
#LUPIN FUT SELL BELOW 733 TGT URS
Like
reply
Reply

💠💠
YOUR FREE EQUITY CASH CALL FOR THIS FORUM TODAY:
SELL LUPIN AT THE VERY BEGINING
STRICT STOP LOSS - 775
1ST TARGET - 759
2ND TARGET - 755
3RD TARGET - 750
## GO WITH SAFER QUANTITY ##
Disclaimer: All my Views/Suggestions/Calls are for Education Purpose Only. Please consult w...
Read more...
Like
reply
Reply
@ansarshaikh • Reputation: 48

Positional buy call sl 740 tgt 818
Like
reply
Reply
@stocktrendr • Reputation: 175

Lupin received five observations from the US health regulator after inspection of its Vizag facility in Andhra Pradesh. The inspection of company's Vizag API manufacturing facility by the United States Food and Drug Administration (USFDA) has been completed, Lupin said in a filin...
Read more...
Like
reply
Reply
@invictotrader • Reputation: 2,085

Lupin gets 5 observations from USFDA for its Vizag facility The inspection was carried out between January 13, 2020 and January 17, 2020, it added.
Like
reply
Reply
@nishantshah91 • Reputation: 3,299
LUPIN

Type
Buy
Instrument
LUPIN
Entry Price
₹769
Price@Trade
₹768.55
Target Price
₹800
Stop Price
₹749
Valid Till
Feb 17, 2020 3:20 PM
Margin
₹769 approx for 1 Qty
Status
Stoploss Hit
Net P&L
-2.6% Loss
Buy Cmp and in dips till 760
Like
reply
Reply (2)
Latest replies
TrackerBot @trackerbot
Jan 17 8:19 PM

Update
Trade Entered
Entry Price
₹769
TrackerBot @trackerbot
Jan 20 3:26 PM

Update
Stoploss Hit
StopLoss
₹749
@rajivkumarjha • Reputation: 30,001
LUPIN JAN20 760 CE

Type
Buy
Instrument
LUPIN JAN20 760 CE
Entry Price
₹15.3
Price@Trade
₹15.3
Target Price
₹40
Stop Price
₹3
Valid Till
Jan 30, 2020 3:20 PM
Margin
₹10,710 approx for 700 Qty
Status
Exited
Exit Price
₹17.7
Net P&L
15.69% Profit
Like
reply
Reply (1)
Latest replies
robotrade @rajivkumarjha
Jan 17 6:38 PM

Update
Exited
Exit Price
₹17.7
Net P&L
15.69% Profit

Lupin’s Troubles In U.S. Run Deep
Five plants of Lupin Ltd. have come under the U.S. drug regulator’s scanner over the last one year as the nation’s sixth-largest drugmaker failed to resolve quality issues amid intense competition and pricing pressure in its largest market.
...
Read more...
Like
reply
Reply
@TradingIdeas • Reputation: -5,945
LUPIN JAN20 FUT

Type
Sell
Instrument
LUPIN JAN20 FUT
Entry Price
₹752.5
Price@Trade
₹752.7
Target Price
₹747
Stop Price
₹757
Valid Till
Jan 15, 2020 3:20 PM
Margin
₹93,104.12 approx for 700 Qty
Status
Stoploss Hit
Net P&L
-3.38% Loss
Like
reply
Reply (2)
Latest replies
TrackerBot @trackerbot
Jan 15 3:26 PM

Update
Trade Entered
Entry Price
₹752.5
TrackerBot @trackerbot
Jan 15 3:45 PM

Update
Stoploss Hit
StopLoss
₹757
@commodityBiz • Reputation: 2,552

LUPIN - chart - 529774
👆👆👆👆👆👆👆👆Suggestion :- SELL IF PRICE COMES AGAIN AT 765 WITH SL OF 768 FOR TARGET OF 754
EXPECTATION OF TARGET- 1 DAYS
SIGNAL TYPE - STRONG TIME FRAME- 1 HOURS
Like
reply
Reply (1)
Latest replies

Ye saala Madarchod ka bacha hai . Iski maa randi hai . Budhiya ko koi nhi chodta to isne yha logon se paisa chori karne ka business khara kar rakha hai . Ye haramkhoro ko kuch nhi aata . Sala iska baap goo saaf karta tha aur iski biwi abhi bhi randi khana join ki hai . bhai log ...
@ravikanthchopperla • Reputation: 10,618
Lupin share price falls 2% after USFDA classifies Tarapur unit as OAI
USFDA inspected company's manufacturing (API) facility between September 16 to September 20.
Moneycontrol
1
reply
Reply
@calls • Reputation: 1,206

*UPDATE*
LUPIN GIVEN AT 770
NOW MADE 742 + 28 * 700 = 19600 PER LOT RUNNING
CHHAPO INDIA CHHAPO
1
reply
Reply
@Vaibhavbarge • Reputation: 24,250

Lupin: The pharma company on Saturday said it has received two observations from the US health regulator following the inspection of its Nagpur manufacturing facility. A prior approval inspection was carried out by the United States Food and Drug Administration at the company's N...
Read more...
Like
reply
Reply
@invictotrader • Reputation: 2,085

Lupin gets 2 observations from USFDA for Nagpur facility "The inspection closed with two 483 observations," Lupin said.
Like
reply
Reply
@Sharemarket • Reputation: -1,368

For Short Term Buy Lupin @ 795 Target 810/840+++ Stop loss 786
Like
reply
Reply
@calls • Reputation: 1,206

lupin weak 770 fo
Like
reply
Reply
@commodityBiz • Reputation: 2,552

LUPIN - chart - 523911
👆👆👆👆👆👆👆👆Suggestion :- SELL IF PRICE COMES AGAIN AT 764 WITH SL OF 767 FOR TARGET OF 754
EXPECTATION OF TARGET- 1 DAYS
SIGNAL TYPE - STRONG TIME FRAME- 1 HOURS
Like
reply
Reply
@rajivkumarjha • Reputation: 30,001
LUPIN JAN20 FUT

Type
Buy
Instrument
LUPIN JAN20 FUT
Entry Price
₹764
Price@Trade
₹764
Target Price
₹784
Stop Price
₹754
Valid Till
Jan 30, 2020 3:20 PM
Margin
₹94,552.36 approx for 700 Qty
Status
Exited
Net P&L
6.63% Profit
Like
reply
Reply (1)
Latest replies
robotrade @rajivkumarjha
Jan 10 2:55 PM

Update
Exited
Exit Price
₹772.95
Net P&L
6.63% Profit
@tradingfab • Reputation: 752

08-01-20 Intraday SELL LUPIN in cash
only Below @ 753
Like
reply
Reply (3)
Latest replies
Sameer  @tradingfab
Jan 8 3:35 PM

LTP 752.30 🔥🔥🔥
Sameer  @tradingfab
Jan 8 5:02 PM

LTP 951.15 🔥🔥💥
Sameer  @tradingfab
Jan 8 5:05 PM

low 750.25 🔥🔥💥💥
@tradingfab • Reputation: 752

08-01-20 Intraday SELL LUPIN in cash
only Below @ 751.50
Like
reply
Reply (1)
Latest replies
Sameer  @tradingfab
Jan 8 3:12 PM

cancel the order as sell price below @751.50 not yet triggered
@ravikanthchopperla • Reputation: 10,618

LUPIN - chart - 518158
Lupin: LCP 757.55 having next supports at 737 and 720 and resistance being at 778 and 815.
Like
reply
Reply
@commodityBiz • Reputation: 2,552

LUPIN - chart - 515506
👆👆👆👆👆👆👆👆Suggestion :- SELL IF PRICE COMES AGAIN AT 765 WITH SL OF 768 FOR TARGET OF 760
EXPECTATION OF TARGET- 1 DAYS
SIGNAL TYPE - STRONG TIME FRAME- 1 HOURS
Like
reply
Reply
@databot • Reputation: 1,382

Motilal Oswal target on LUPIN
Date: 12-Nov-19 Broker: Motilal Oswal Price @ Call: 731.45 Target: 860 Recommendation: BUY
Like
reply
Reply
@databot • Reputation: 1,382

Motilal Oswal target on LUPIN
Date: 12-Nov-19 Broker: Motilal Oswal Price @ Call: 731.45 Target: 860 Recommendation: BUY
Like
reply
Reply
@rogueniftytrader • Reputation: -1,150

LUPIN - chart - 501611
#DDCharts #triangle
#lupin possibilities
Like
reply
Reply

LUPIN - 501518
Performance
Entry 759.00 to 772.95
*profit 9800*
Like
reply
Reply (2)
Latest replies
Kiran Tangudu @kirantangudu
Dec 29 11:28 AM

Can I have your contact number please

Good morning, u can connect on 9845031889
@invictotrader • Reputation: 2,085

Lupin's Ankleshwar Facility Wins Frost & Sullivan's India Manufacturing Excellence Awards 2019
Like
reply
Reply
@commodityBiz • Reputation: 2,552

LUPIN - chart - 498482
👆👆👆👆👆👆👆👆Suggestion :- SELL IF PRICE COMES AGAIN AT 759 WITH SL OF 767 FOR TARGET OF 475
EXPECTATION OF TARGET- 1-2 DAYS
SIGNAL TYPE - STRONG TIME FRAME- 1 HOURS
Like
reply
Reply
@calls • Reputation: 1,206

*UPDATE*
LUPIN 770 TO 758 + 12*700 = 8400
CHAPO INDIA CHAPO
Like
reply
Reply
@rachanaGoldforest • Reputation: 403
Goldforest in LUPIN
Sell lupin 769 Target 765-61 Sl 774

All done 💰💰💰💰💰💸💸💸
Like
reply
Reply
@rachanaGoldforest • Reputation: 403
Goldforest in LUPIN
Sell lupin 769 Target 765-61 Sl 774

T1done 💰💰💰💰
1
reply
Reply
@rachanaGoldforest • Reputation: 403
Goldforest in LUPIN
Sell lupin 769 Target 765-61 Sl 774

766.05🔥🔥🔥🔥
1
reply
Reply
@rachanaGoldforest • Reputation: 403
Goldforest in LUPIN
Sell lupin 769 Target 765-61 Sl 774

767.25🔥🔥🔥🔥
1
reply
Reply
@rachanaGoldforest • Reputation: 403

Sell lupin 769
Target 765-61
Sl 774
Like
reply
Reply
@TTA • Reputation: 8,717

Lupin has got USFDA approval for the generic version of Merck's Diprolene (Betamethasone Dipropionate) ointment, 0.05% in US. The drug, a corticosteroid indicated for relief from certain skin conditions, had annual sales of ~US$22 million in the US (IQVIA MAT September 2019). The...
Read more...
Like
reply
Reply

Futures & Options educational trades for the week 23.12.19 to 27.12.19*
(My trade rules given below apply)
Lupin* cmp 772.10 buy upto 755.00 stop 743.00 target 814.00+
1
reply
Reply
@commodityBiz • Reputation: 2,552

LUPIN - chart - 492923
👆👆👆👆👆👆👆👆Suggestion :- BUY IF PRICE COMES AGAIN BETWEEN 771-771.50 WITH SL OF 768 FOR TARGET OF 778
EXPECTATION OF TARGET- 1 DAYS
SIGNAL TYPE - STRONG TIME FRAME- 1 HOURS
Like
reply
Reply
@invictotrader • Reputation: 2,085

Lupin receives approval for Betamethasone Dipropionate Ointment USP (Augmented)
Like
reply
Reply
@invictotrader • Reputation: 2,085

Lupin gets USFDA nod to market skin ointment The approval by the United States Food and Drug Administration (USFDA) is to market its generic Betamethasone Dipropionate ointment USP (augmented), 0.05 per cent, it added.
Like
reply
Reply
@invictotrader • Reputation: 2,085

Lupin launches Doxercalciferol injection
Like
reply
Reply
@invictotrader • Reputation: 2,085

Lupin's Alliance Partner Concord Receives Approval for Mycophenolic Acid Delayed Release Tablets USP
Like
reply
Reply
@invictotrader • Reputation: 2,085

Lupin share price gains on USFDA nod for Mycophenolic drug With this approval, the company said it would market a generic equivalent of Myfortic delayed release tablets of Novartis Pharmaceuticals Corporation,
Like
reply
Reply
  • LUPIN - Share Price - Fundamentals

    keyboard_arrow_down
    Market Capitalization33,444.28
    Enterprise Value33,384.84
    Price to Earnings24.77
    Price to Book Value1.95
    Return on Capital Employed0.12
    Return on Equity0.09
    Face Value2
    Dividend Yield0.01
  • LUPIN Share Price - Technicals

    keyboard_arrow_down
    LUPIN - 52 Week High₹888.65
    LUPIN - 52 Week Low₹646.3
  • LUPIN - Brokerage Reports

    keyboard_arrow_down
    DateBrokerageCallTarget
    26-Nov-19Nirmal BangAccumulate824
    13-Nov-19Prabhudas LilladherHold760
    12-Nov-19Motilal OswalBuy860
    6-Nov-19Prabhudas LilladherReduce730
    9-Aug-19Prabhudas LilladherReduce730
    LUPIN Brokerage Price Target
  • LUPIN Share Price - Historical (₹)

    keyboard_arrow_down
    DateOpenHighLowClose
    Jan 24737.3744.5735.7740.15
    Jan 23738.4743.95736737.85
    Jan 22743.25746.95734.65738.4
    Jan 21733744.25727.25741.15
    Jan 20760760.25730.1732.7
  • LUPIN Share Price - Daily Moving Averages (DMA)

    keyboard_arrow_down
    20 Day Moving Average₹755.75
    30 Day Moving Average₹758.07
    50 Day Moving Average₹763.69
    100 Day Moving Average₹749.46
    200 Day Moving Average₹760.08
  • LUPIN - Profit And Loss

    keyboard_arrow_down
    CONSOLIDATEDMar-18Mar-17 % Change
    Revenue10,08012,753.15-0.21
    Operating Profit2,0864,486.12-0.54
    Profit Before Tax1,7934,179.06-0.57
    Net Income1,3443,141.33-0.57
  • LUPIN - Balance Sheet

    keyboard_arrow_down
    CONSOLIDATEDMar-19Mar-18 % Change
    Shareholder's Funds17,11715,7840.08
    Total Liabilities2,5733,042-0.15
    Total Assets19,69018,8270.05
  • LUPIN - Cash Flow

    keyboard_arrow_down
    CONSOLIDATEDMar-18Mar-17 % Change
    Cash from Operating Activity2154,353.33-0.95
    Cash from Investing Activity-1,159-1,941.79-0.4
    Cash from Financing Activity-986-160.025.16
    Net Cash Flow-1,9312,251.52-1.86
  • LUPIN - Ratios

    keyboard_arrow_down
    CONSOLIDATEDMar-18Mar-17
    Return on Assets0.070.17
    Return on Equity0.090.21
    Return on Capital Employed0.120.27
  • LUPIN - 3 year Growth

    keyboard_arrow_down
    3 Year CAGR Growth in Revenue0.03
    3 Year CAGR Growth in Operating Profit-0.38
    3 Year CAGR Growth in EBIDTA-0.38
    3 Year CAGR Growth in Net Income-0.44
    3 Yr CAGR Growth - Diluted EPS-0.44
  • LUPIN - 5 year Growth

    keyboard_arrow_down
    5 Year CAGR Growth in Revenue0.42
    5 Year CAGR Growth in Operating Profit0.11
    5 Year CAGR Growth in EBIDTA0.16
    5 Year CAGR Growth in Net Income0.07
    3 Yr CAGR Growth - Diluted EPS0.06
  • LUPIN - Recent News

    keyboard_arrow_down
    NewsBot
    Oct 23 4:13 PM
    Rakesh Jhunjhunwala raises stake in 5 stocks which fell up to 40% in 2019
    Moneycontrol
    NewsBot
    Oct 23 3:43 PM
    Q2 portfolio rejig: Rakesh Jhunjhunwala raises stake in 5 stocks which fell up to 40% in 2019
    Moneycontrol
    NewsBot
    Oct 23 2:23 PM
    Market Headtstart: Nifty50 seen opening flat; Axis Bank, RBL Bank in focus
    Moneycontrol
    NewsBot
    Oct 18 9:28 PM
    Lupin gains 2% as Nagpur unit receives EIR from USFDA
    Moneycontrol
    NewsBot
    Oct 14 9:18 PM
    Lupin Q2 PAT may dip 22% YoY to Rs. 206.5 cr: Emkay
    Moneycontrol
    NewsBot
    Oct 14 1:53 PM
    Stocks in the news: Infosys, Avenue Supermart, BoB, NMDC, Cadila Health, HUL
    Moneycontrol
    NewsBot
    Oct 14 1:23 PM
    Market Headstart: Nifty seen opening flat; Bharti Airtel, HUL top buys
    Moneycontrol
    NewsBot
    Oct 14 1:03 PM
    A morning walk down Dalal Street | Nifty may test 11,400 if it stays above 11,189; HUL in focus
    Moneycontrol
    NewsBot
    Oct 12 2:33 AM
    Lupin plans to file Etanercept, Pegfilgrastim biosimilars in US by Q4FY20
    Moneycontrol
    NewsBot
    Oct 10 4:48 PM
    Morgan Stanley bullish on these 2 pharma stocks which could give 32-47% return
    Moneycontrol
  • LUPIN - Related Communities

    keyboard_arrow_down
    Sun Pharmaceutical Industries Ltd. S...
    Aurobindo Pharma Ltd. Sector: Pharma...
    Biocon Ltd. Sector: Pharmaceuticals ...
    Cipla Ltd. Sector: Pharmaceuticals a...
    Lupin Ltd. Sector: Pharmaceuticals an...
    Dr. Reddy's Laboratories Ltd. Sector...
    Piramal Enterprises Ltd. Sector: Phar...
    Glenmark Pharmaceuticals Ltd. Sector...
    Divi's Laboratories Ltd. Sector: Pha...
    Strides Pharma Science Ltd. Sector: P...
SOURCE: Data from D'Market via Quandl. Intraday data delayed 15 minutes.
DISCLAIMER: Information is provided "as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and FrontPage will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein.